ENDOPHASE
Peptides / Magainin / Aggregation Risk
Aggregation Risk

Aggregation Risk for Magainin

The cheapest time to catch a problem with a peptide is while it is still just text on a screen. EndoPhase gives you a read on the hydrophobic runs and motifs that tend to drive aggregation, for Magainin and any sequence you are weighing up.

Run Magainin preflight

The cheapest time to catch a problem with a peptide is while it is still just text on a screen. For a candidate like Magainin, the questions worth answering early are practical: is the sequence clean to make, is it stable, and does the intended route even make sense. aggregation risk is the part of that picture EndoPhase focuses on here.

What aggregation risk looks at

For Magainin, EndoPhase surfaces a read on the hydrophobic runs and motifs that tend to drive aggregation, in plain language, with the reasoning kept beside the result so a reviewer can agree or push back.

Why do this before synthesis

A good decision layer turns a risky guess into a documented, reviewable call. The whole idea is to spend judgement before spending budget. A few minutes of preflight beats a wasted synthesis run every time.

Request beta access

EndoPhase is research-use software. It does not sell peptides, give medical advice, diagnose, treat, or make claims about the safety or efficacy of any compound named here. Names are used as analysis subjects only.